Administration of probiotics influences F4 (K88)-positive enterotoxigenic Escherichia coli attachment and intestinal cytokine expression in weaned pigs

Veterinary Research

Volumn 42, Issue 1, 2011, Pages

  Daudelin, Jean François ^a,b   Lessard, Martin ^a   Beaudoin, Frédéric ^a   Nadeau, Éric ^b   Bissonnette, Nathalie ^a   Boutin, Yvan ^c   Brousseau, Jean Philippe ^a   Lauzon, Karoline ^a   Fairbrother, John ^b  

^a SHERBROOKE RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c TransBiotech   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PEDIOCOCCUS ACIDILACTICI; SACCHAROMYCES CEREVISIAE; SUIDAE;

CYTOKINE; PROBIOTIC AGENT;

ANIMAL; ANIMAL DISEASE; ANIMAL FOOD; ARTICLE; BACTERIUM ADHERENCE; CHEMISTRY; DIET; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GENETICS; INTESTINE; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PEDIOCOCCUS; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; STOMACH JUICE; SWINE; SWINE DISEASE; WEANING;

ANIMAL FEED; ANIMALS; BACTERIAL ADHESION; CYTOKINES; DIET; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GASTROINTESTINAL CONTENTS; INTESTINAL MUCOSA; INTESTINES; PEDIOCOCCUS; PROBIOTICS; REAL-TIME POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; SWINE; SWINE DISEASES; WEANING;

EID: 80052017608     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-42-69     Document Type: Article

References (33)

1. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Fairbrother JM, Nadeau E, Gyles CL, Anim Health Res Rev 2005 6 1 17 39 10.1079/AHR2005105 16164007
2. Immunomodulatory effects of probiotics in the intestinal tract. Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y, Roy D, Curr Issues Mol Biol 2008 10 1-2 37 54 18525105 (Pubitemid 351756577)
3. Probiotic lactobacilli and VSL#3 induce enterocyte -defensin 2. Schlee M, Harder J, Koten B, Stange EF, Wehkamp J, Fellermann K, Clin Exp Immunol 2008 151 3 528 535 10.1111/j.1365-2249.2007.03587.x 18190603 (Pubitemid 351160737)
4. Influence of Pediococcus-based probiotic on coccidiosis in broiler chickens. Lee SH, Lillehoj HS, Dalloul RA, Park DW, Hong YH, Lin JJ, Poult Sci 2007 86 1 63 66 17179417 (Pubitemid 46021303)
5. Live yeast dietary supplementation acts upon intestinal morpho-functional aspects and growth in weanling piglets. Bontempo V, Di Giancamillo A, Savoini G, Dell'orto V, Domeneghini C, Anim Feed Sci Technol 2006 129 3-4 224 236 10.1016/j.anifeedsci.2005.12.015 (Pubitemid 44107646)
6. Effects of orally administered probiotic Pediococcus acidilactici on the small and large intestine of weaning piglets. A qualitative and quantitative micro-anatomical study. Di Giancamillo A, Vitari F, Savoini G, Bontempo V, Bersani C, Dell'Orto V, Domeneghini C, Histol Histopathol 2008 23 6 651 664 18366003 (Pubitemid 351552350)
7. Administration of Pediococcus acidilactici or Saccharomyces cerevisiae boulardii modulates development of porcine mucosal immunity and reduces intestinal bacterial translocation after Escherichia coli challenge. Lessard M, Dupuis M, Gagnon N, Nadeau E, Matte JJ, Goulet J, Fairbrother JM, J Anim Sci 2009 87 3 922 934 19028865
8. Evaluation of bacterial diversity in the gut of piglets supplemented with probiotics using ribosomal intergenic spacer analysis. Gagnon N, Talbot G, Ward P, Roy D, Dupuis M, Farnworth E, Tompkins TA, Lessard M, Can J Anim Sci 2007 87 2 207 219 10.4141/A06-065 (Pubitemid 47138222)
9. Effets de Pediococcus acidilactici et Saccharomyces cerevisiae boulardii sur le microbiote iléal du porcelet sevré Brousseau JP, Beaudoin F, Lauzon K, Talbot G, Roy D, Lessard M, 6th International Symposium on Probiotics: October 2010; Montreal 2010 (in French)
10. Guidelines on the care and use of farm animal in research, teaching and testing. CCAC, Canadian Council on Animal Care, Ottawa, ON, Canada 2009
11. Experimental infection with Escherichia coli O149:F4ac in weaned piglets. Jensen GM, Frydendahl K, Svendsen O, Jorgensen CB, Cirera S, Fredholm M, Nielsen JP, Moller K, Vet Microbiol 2006 115 1-3 243 249 10.1016/j.vetmic.2006. 01.002 16466864 (Pubitemid 43786360)
12. LAMVAB-A new selective medium for the isolation of lactobacilli from faeces. Hartemink R, Domenech VR, Rombouts FM, J Microbiol Methods 1997 29 2 77 84 10.1016/S0167-7012(97)00025-0 (Pubitemid 27319830)
13. Spray-dried plasma improves growth performance and reduces inflammatory status of weaned pigs challenged with enterotoxigenic Escherichia coli K88. Bosi P, Casini L, Finamore A, Cremokolini C, Merialdi G, Trevisi P, Nobili F, Mengheri E, J Anim Sci 2004 82 6 1764 1772 15217004 (Pubitemid 38717900)
14. Effect of Orally Administered probiotic E. coli strain Nissle 1917 on intestinal mucosal immune cells of healthy young pigs. Duncker SC, Lorentz A, Schroeder B, Breves G, Bischoff SC, Vet Immunol Immunopathol 2006 111 3-4 239 250 10.1016/j.vetimm.2006.01.017 16530848
15. Quantitative analysis of the immune response upon Salmonella typhimurium infection along the porcine intestinal gut. Collado-Romero M, Arce C, Ramirez-Boo M, Carvajal A, Garrido JJ, Vet Res 2010 41 2 23 10.1051/vetres/ 2009072 19941811
16. IDT SciTools PrimerQuest Software. http://www.idtdna.com/Scitools/ Applications/Primerquest
17. Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease. Bosworth B, Ridpath J, Wiseman B, USA: United States Biotechnology Research and Development Corporation (Peoria, IL), Volume 6355859, The United States of America as represented by the Department of Agriculture (Washington, DC) 2002
18. The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage. Roselli M, Finamore A, Britti MS, Konstantinov SR, Smidt H, de Vos WM, Mengheri E, J Nutr 2007 137 12 2709 2716 18029488 (Pubitemid 350255302)
19. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Zareie M, Johnson-Henry K, Jury J, Yang PC, Ngan BY, McKay DM, Soderholm JD, Perdue MH, Sherman PM, Gut 2006 55 11 1553 1560 10.1136/gut.2005.080739 16638791 (Pubitemid 44629200)
20. A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica Serovar Typhimurium. Casey PG, Gardiner GE, Casey G, Bradshaw B, Lawlor PG, Lynch PB, Leonard FC, Stanton C, Ross RP, Fitzgerald GF, Hill C, Appl Environ Microbiol 2007 73 6 1858 1863 10.1128/AEM.01840-06 17261517 (Pubitemid 46449068)
21. Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. Shu Q, Qu F, Gill HS, J Pediatr Gastroenterol Nutr 2001 33 2 171 177 10.1097/00005176-200108000-00014 11568519 (Pubitemid 32802815)
22. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. Carey CM, Kostrzynska M, Ojha S, Thompson S, J Microbiol Methods 2008 73 2 125 132 10.1016/j.mimet.2008.01.014 18328583
23. Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Ruiz PA, Hoffmann M, Szcesny S, Blaut M, Haller D, Immunology 2005 115 4 441 450 10.1111/j.1365-2567.2005.02176.x 16011513 (Pubitemid 41032432)
24. Effect of intestinal epithelial cell cytokines on mucosal B-cell IgA secretion: enhancing effect of epithelial-derived IL-6 but not TGF- on IgA+ B cells. Goodrich ME, McGee DW, Immunol Lett 1999 67 1 11 14 10.1016/S0165- 2478(98)00112-6 10217200 (Pubitemid 29143429)
25. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Haller D, Bode C, Hammes WP, Pfeifer AMA, Schiffrin EJ, Blum S, Gut 2000 47 1 79 87 10.1136/gut.47.1.79 10861268 (Pubitemid 30430415)
26. Porcine -defensin 2 displays broad antimicrobial activity against pathogenic intestinal bacteria. Veldhuizen EJ, Rijnders M, Claassen EA, van Dijk A, Haagsman HP, Mol Immunol 2008 45 2 386 394 10.1016/j.molimm.2007.06.001 17658606 (Pubitemid 47332639)
27. Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma. Simmons CP, Goncalves NS, Ghaem-Maghami M, Bajaj-Elliott M, Clare S, Neves B, Frankel G, Dougan G, MacDonald TT, J Immunol 2002 168 4 1804 1812 11823513 (Pubitemid 34135780)
28. Lactobacilli and Streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Miettinen M, Matikainen S, Vuopio-Varkila J, Pirhonen J, Varkila K, Kurimoto M, Julkunen I, Infect Immun 1998 66 12 6058 6062 9826398 (Pubitemid 28531878)
29. Toll-like receptor 4 and cytokine expression involved in functional immune response in an originally established porcine intestinal epitheliocyte cell line. Moue M, Tohno M, Shimazu T, Kido T, Aso H, Saito T, Kitazawa H, Biochim Biophys Acta 2008 1780 2 134 144 18082146
30. Cytokine mRNA expression in porcine cell lines stimulated by enterotoxigenic Escherichia coli. Pavlova B, Volf J, Alexa P, Rychlik I, Matiasovic J, Faldyna M, Vet Microbiol 2008 132 1-2 105 110 10.1016/j.vetmic. 2008.04.024 18514441
31. Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. Roselli M, Finamore A, Britti MS, Mengheri E, Br J Nutr 2006 95 6 1177 1184 10.1079/BJN20051681 16768842 (Pubitemid 43985998)
32. Gamma interferon production by hepatic NK T cells during Escherichia coli infection is resistant to the inhibitory effects of oxidative stress. Zhang G, Nichols RD, Taniguchi M, Nakayama T, Parmely MJ, Infect Immun 2003 71 5 2468 2477 10.1128/IAI.71.5.2468-2477.2003 12704118 (Pubitemid 36519859)
33. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-B-mediated IL-8 gene expression. Sougioultzis S, Simeonidis S, Bhaskar KR, Chen X, Anton PM, Keates S, Pothoulakis C, Kelly CP, Biochem Biophys Res Commun 2006 343 1 69 76 10.1016/j.bbrc.2006.02.080 16529714